{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T12:01:19Z","timestamp":1752667279879,"version":"3.37.3"},"reference-count":38,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jcehepatology.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.jceh.2024.101388","type":"journal-article","created":{"date-parts":[[2024,2,27]],"date-time":"2024-02-27T17:21:12Z","timestamp":1709054472000},"page":"101388","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Risk Factors for Development of Cirrhosis in Chronic Viral Hepatitis B Patients Who Had Persistent Viral Suppression With Antiviral Therapy"],"prefix":"10.1016","volume":"14","author":[{"given":"Soe T.","family":"Maung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8460-9563","authenticated-orcid":false,"given":"Pakanat","family":"Decharatanachart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sombat","family":"Treeprasertsuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roongruedee","family":"Chaiteerakij","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2024.101388_bib1","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1016\/S2468-1253(22)00124-8","article-title":"Global, regional, and national burden of hepatitis B, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"7","author":"Sheena","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101388_bib2","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1053\/jhep.2001.29401","article-title":"Chronic hepatitis B","volume":"34","author":"Lok","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101388_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cld.2004.02.008","article-title":"Hepatitis B: epidemiology and natural history","volume":"8","author":"Tran","year":"2004","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2024.101388_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1053\/j.gastro.2005.11.016","article-title":"Predicting cirrhosis risk based on the level of circulating hepatitis B viral load","volume":"130","author":"Iloeje","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101388_bib5","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJMoa051285","article-title":"A\u00a0comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B","volume":"354","author":"Chang","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2024.101388_bib6","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1053\/j.gastro.2006.09.020","article-title":"Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B for up to 5 years","volume":"131","author":"Hadziyannis","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101388_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during\u00a0treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.jceh.2024.101388_bib8","first-page":"506","article-title":"Antiviral therapy leads to histological improvement in HBeAg-negative chronic hepatitis B patients","author":"Basyigit","year":"2015","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101388_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/00042737-200012060-00019","article-title":"Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study","volume":"12","author":"Wu","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101388_bib10","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2012.02.010","article-title":"EASL clinical practice guidelines: management of chronic hepatitis B virus infection","volume":"57","year":"2012","journal-title":"J\u00a0Hepatol"},{"year":"2011","series-title":"Hepatitis B virus and human immunodeficiency virus co-infection: a perspective from sub-Saharan African and South Africa","author":"Burnett","key":"10.1016\/j.jceh.2024.101388_bib11"},{"key":"10.1016\/j.jceh.2024.101388_bib12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.23190","article-title":"Chronic hepatitis B: update 2009","volume":"50","author":"Lok","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101388_bib13","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/jgh3.12219","article-title":"Evaluation of aspartate aminotransferase to platelet ratio index and fibrosis 4 scores for hepatic fibrosis assessment compared with transient elastography in chronic hepatitis C patients","volume":"4","author":"Sripongpun","year":"2020","journal-title":"JGH Open"},{"key":"10.1016\/j.jceh.2024.101388_bib14","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/hep.1840080310","article-title":"The development of cirrhosis in patients with chronic type B hepatitis: a prospective study","volume":"8","author":"Liaw","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101388_bib15","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00004836-200004000-00009","article-title":"Diabetes mellitus as a risk factor of liver cirrhosis in patients with chronic hepatitis B virus infection","volume":"30","author":"Huo","year":"2000","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101388_bib16","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s12072-011-9274-y","article-title":"The dissociation between the diabetes and both Child\u2013Pugh score and in-hospital mortality in cirrhotic patients due to hepatitis B, hepatitis C, or alcoholic","volume":"5","author":"Chen","year":"2011","journal-title":"Hepatology International"},{"key":"10.1016\/j.jceh.2024.101388_bib17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/jhep.2001.28055","article-title":"High glucose and hyperinsulinemia stimulate connective tissue growth factor expression: a potential mechanism involved in progression to fibrosis in nonalcoholic steatohepatitis","volume":"34","author":"Paradis","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101388_bib18","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/cid\/cit603","article-title":"Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study","volume":"57","author":"Huang","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2024.101388_bib19","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jfma.2017.09.002","article-title":"Elevated body mass index is a risk factor associated with possible liver cirrhosis across different etiologies of chronic liver disease","volume":"117","author":"Yen","year":"2018","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.jceh.2024.101388_bib20","doi-asserted-by":"crossref","first-page":"5576","DOI":"10.1200\/JCO.2008.16.1075","article-title":"Body-mass index and progression of hepatitis B: a population-based cohort study in men","volume":"26","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2024.101388_bib21","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1053\/j.gastro.2017.07.001","article-title":"Influence of metabolic risk factors on risk of hepatocellular carcinoma and liver-related death in men with chronic hepatitis B: a large cohort study","volume":"153","author":"Yu","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2024.101388_bib22","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/jvh.13345","article-title":"High body mass index hinders fibrosis improvement in patients receiving long-term tenofovir therapy in hepatitis B virus-related cirrhosis","volume":"27","author":"Chon","year":"2020","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2024.101388_bib23","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101388_bib24","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jhep.2011.09.013","article-title":"Hepatitis B virus infection and fatty liver in the general population","volume":"56","author":"Wong","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2024.101388_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1136\/gut.2008.157735","article-title":"Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B","volume":"58","author":"Wong","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2024.101388_bib26","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/apt.12658","article-title":"Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B\u2013a prospective cohort study with paired transient elastography examinations","volume":"39","author":"Wong","year":"2014","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.jceh.2024.101388_bib27","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1111\/j.1572-0241.2002.07057.x","article-title":"Effect of hepatitis B and C virus infections on the natural history of compensated cirrhosis: a cohort study of 297 patients","volume":"97","author":"Fattovich","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2024.101388_bib28","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/apt.14352","article-title":"The negative impact of HBV\/HCV coinfection on cirrhosis and its consequences","volume":"46","author":"Pol","year":"2017","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.jceh.2024.101388_bib29","first-page":"746","article-title":"Spectrum of liver disease in hepatitis B virus (HBV) patients co-infected with human immunodeficiency virus (HIV): results of the HBV-HIV cohort study","volume":"114","author":"Sterling","year":"2019","journal-title":"Off J Am College Gastroenterol|ACG"},{"key":"10.1016\/j.jceh.2024.101388_bib30","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101388_bib31","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cgh.2010.11.040","article-title":"Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B","volume":"9","author":"Schiff","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101388_bib32","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/jgh.12718","article-title":"Long-term lamivudine treatment achieves\u00a0regression of advanced liver fibrosis\/cirrhosis in patients\u00a0with chronic hepatitis B","volume":"30","author":"Xu","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2024.101388_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1002\/cld.977","article-title":"Affordability of Antiviral Therapy in Asia-Pacific Countries and Its Impact on Public Health Outcomes","volume":"16","author":"Udompap","year":"2020","journal-title":"Clinical Liver Disease"},{"key":"10.1016\/j.jceh.2024.101388_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.23246","article-title":"Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside\/nucleotide analogues","volume":"51","author":"van B\u00f6mmel","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2024.101388_bib35","article-title":"Prediction of liver-related events using fibroscan in chronic hepatitis B patients showing advanced liver fibrosis","volume":"7","author":"Kim","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2024.101388_bib36","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1111\/apt.12307","article-title":"Non-invasive tests for fibrosis and liver stiffness predict 5-year survival of patients chronically infected with hepatitis B virus","volume":"37","author":"De L\u00e9dinghen","year":"2013","journal-title":"Aliment Pharmacol Therapeut"},{"key":"10.1016\/j.jceh.2024.101388_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.5009\/gnl14170","article-title":"Disease progression in chronic hepatitis B patients under long-term antiviral therapy","volume":"9","author":"Moon","year":"2015","journal-title":"Gut and Liver"},{"key":"10.1016\/j.jceh.2024.101388_bib38","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1136\/gutjnl-2013-306409","article-title":"Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease","volume":"63","author":"Cho","year":"2014","journal-title":"Gut"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688324000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T04:57:17Z","timestamp":1719637037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688324000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S0973688324000458"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101388","relation":{},"ISSN":["0973-6883"],"issn-type":[{"type":"print","value":"0973-6883"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk Factors for Development of Cirrhosis in Chronic Viral Hepatitis B Patients Who Had Persistent Viral Suppression With Antiviral Therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2024.101388","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101388"}}